Buprenorphine Formulations for the Treatment of Opioid Use Disorders: Comparative Clinical Effectiveness, Cost-Effectiveness, and Guidelines


( Last Updated : April 2, 2018)
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA0951-000

Details


Question


  1. What is the comparative clinical effectiveness of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?

  2. What is the cost-effectiveness of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?

  3. What are the evidence-based guidelines regarding the use of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders?


Key Message

One economic evaluation and two evidence-based guidelines were identified on the use of various buprenorphine or buprenorphine/naloxone formulations for the treatment of opioid use disorders.